TGFB2 and neoplasm: Although these investigators reported encouraging results, such as the suppression of TGF-β2 expression and suppression of tumor growth, the investigators did not use a suitable ASO control to confirm that the observed tumor and immune response was not triggered by the modified oligonucleotide.